elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Methyltransferase
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Methyltransferase
RIS
0.004
(Research Intensity Score)
Papers
454
Top papers
Epigenetics-targeted drugs: current paradigms and future challenges
2024 · 300 citations
Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer
2023 · 434 citations
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia
2023 · 496 citations
Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells
2022 · 781 citations
The Effects of Cadmium Toxicity
2020 · 2720 citations
Newest papers
A generalized platform for artificial intelligence-powered autonomous enzyme engineering
2025 · 98 citations
Nrf3-Mediated Mitochondrial Superoxide Promotes Cardiomyocyte Apoptosis and Impairs Cardiac Functions by Suppressing Pitx2
2025 · 49 citations
HDAC2‐Mediated METTL3 Delactylation Promotes DNA Damage Repair and Chemotherapy Resistance in Triple‐Negative Breast Cancer
2025 · 43 citations
KRAS mutants confer platinum resistance by regulating ALKBH5 posttranslational modifications in lung cancer
2025 · 32 citations
TRIM21-mediated METTL3 degradation promotes PDAC ferroptosis and enhances the efficacy of Anti-PD-1 immunotherapy
2025 · 21 citations
A sample from the 100 top papers behind Methyltransferase.
Create a free account to browse them all →
Methyltransferase's history
Research intensity over time
Explore Methyltransferase's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Methyltransferase's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link